Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter earnings of $917.7 million. On a per-share basis, the Tarrytown, New York-based company said it had profit of $8.06.

Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and commercializes medicines for treating various serious medical conditions.

Regeneron Pharmaceuticals Inc. (REGN) on Tuesday reported fourth-quarter net income of $917.7 million. The Tarrytown, New York-based company said it had net income of $8.06 per share. Earnings ...